1.
Maraviroc Prevents Optic Nerve Injury-Induced Retinal Ganglion Cell Apoptosis by Modulating the CCL5/CCR5/CTSS Axis.
Huang Jingqiu, Chang Zhaohui, Liu Lian, Lai Cheng, Deng Xizhi, Jiang Bin et al.
Invest Ophthalmol Vis SciJun 20252 citationsBasic Science
Maraviroc, a CCR5 inhibitor, prevented retinal ganglion cell death and preserved optic nerve function in an injury model by modulating the CCL5/CCR5/CTSS pathway. This suggests a promising neuroprotective strategy for glaucoma.